Donna Hackett Email & Phone Number

I head up all commercial aspects of activity undertaken within Translation including commercial analysis, IP and transaction negotiation and also general commercial deal negotiations. I work collaboratively with the rest of the Business Office team and others within the Crick to ensure the business development activity maximises impact and speed of health benefit.Recent transactions include spinning out Adendra Therapeutics with Apple Tree Partners for $53m, where I am the Crick’s Board Observer and spinning out a proteomics company involving funding from a strategic investor.

London, United Kingdom

KDH BioManagement provides a broad and extensive range of expertise including commercial strategy and partnering, due diligence, valuation, intellectual property management and commercial negotiation for life science companies and Institutes.Many small companies do not have all the in-house expertise required and we are happy to ensure the areas of finance, HR and IT are appropriately covered.We are happy to discuss any assignment, from a review of an invention to determine potential commercial value, business planning through project or interim management to NED positions.

Cambridge, United Kingdom

Focused on the transactional, IP and legal aspects of Abzena, a company providing technologies and complementary services across biology, chemistry and manufacturing, including antibody drug conjugates.Highlights include:Significant partnering activity for both antibody drug conjugate and composite human antibody technologies with a bio dollar value in excess of $700m plus royalties.Established Denceptor, an immune oncology joint venture with Baylor Scott and White.

London, United Kingdom

Broader Board level management in addition to commercial development

London, United Kingdom

All commercial and business development activity, including delivering on business strategy, commercial and legal negotiations and intellectual property strategy and prosecution.

Biotechnology business development including partnering in and out of early and late stage assets; commercial and intellectual property due diligence; deal valuations

Headed up the biomedical side of University College London's (UCL)technology transfer activity. Biomedicine accounted for around 80% of research at UCL. This included due diligence on potential opportunities, licensing and spin-outs

New Venture Development

Barrister, Law

Post Graduate Diploma, Law

Diploma In Management Studies

Post Graduate Diploma In Marketing

Bsc Hons, Biochemistry